...
首页> 外文期刊>Indian heart journal >Efficacy of serum blood urea nitrogen, creatinine and electrolytes in the diagnosis and mortality risk assessment of patients with acute coronary syndrome
【24h】

Efficacy of serum blood urea nitrogen, creatinine and electrolytes in the diagnosis and mortality risk assessment of patients with acute coronary syndrome

机译:血清尿素氮,肌酐和电解质在急性冠脉综合征患者诊断和死亡风险评估中的作用

获取原文
           

摘要

Background Although blood urea nitrogen (BUN), creatinine (Cr) and electrolytes are not the mainstay of diagnosis in acute coronary syndrome (ACS) patients but they may have a role in providing a more detailed view of the complications and mortality rates. The aim of this study was to determine the efficacy of these parameters in the diagnosis and mortality risk-assessment of patients with ACS. Methodology A total of 200 patients with ACS were recruited in this prospective study. The relationship of serum BUN, Cr and electrolytes with cardiac enzymes, Global Registry of Acute Coronary Events (GRACE) and mortality was assessed during a 6-months follow-up. Statistical test like multivariate linear regression and binary logistic regression analysis were applied. Results On multivariate linear regression analysis, serum potassium (K) (Unstandardized Coefficient B = ?3.77; p = 0.04) showed significant negative association with Creatine Kinease and serum BUN (Unstandardized Coefficient B = 0.52; p = 0.001) showed significant positive association with Troponin I. The patients with GRACE > 105 had significantly higher levels of serum BUN and Cr. Receiver operating characteristic curves showed that area under curve (AUC) of BUN (0.7) was higher than AUC of Cr (0.5). Multiple adjusted model showed that patients with BUN > 32.5 mg/dl were almost 20 times more likely to be associated with mortality as compared to reference group. Conclusion In addition to cardiac enzymes, K along with BUN and Cr may serve as important aid in diagnosis of ACS. BUN and Cr may also serve as important tools in mortality-risk assessment of ACS patients.
机译:背景技术尽管血尿素氮(BUN),肌酐(Cr)和电解质不是急性冠状动脉综合征(ACS)患者的主要诊断手段,但它们可能有助于更详细地了解并发症和死亡率。这项研究的目的是确定这些参数在ACS患者的诊断和死亡风险评估中的功效。方法这项前瞻性研究共招募了200名ACS患者。在6个月的随访中评估了血清BUN,Cr和电解质与心脏酶,急性冠脉事件全球登记表(GRACE)和死亡率之间的关系。应用了多元线性回归和二元逻辑回归分析等统计检验。结果在多元线性回归分析中,血清钾(K)(非标准系数B = 3.77; p = 0.04)与肌酸激酶显着负相关,血清BUN(非标准系数B = 0.52; p = 0.001)与肌酸激酶显着正相关。肌钙蛋白I。GRACE> 105的患者血清BUN和Cr水平明显升高。接收器工作特性曲线表明,BUN(0.7)的曲线下面积(AUC)高于Cr(0.5)的AUC。多重校正模型显示,与参考组相比,BUN> 32.5 mg / dl的患者与死亡相关的可能性几乎高20倍。结论除心脏酶外,K与BUN和Cr一起可能是诊断ACS的重要辅助手段。 BUN和Cr也可以作为ACS患者死亡风险评估的重要工具。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号